Search research articles
Contact Us
Filters
Showing results (421-430 of 459) with videos related to
Page
of 46
Sort By:
Nature Communications
|
August 16, 2012
Laser-induced ultrafast demagnetization in the presence of a nanoscale magnetic domain network
Boris Vodungbo, Julien Gautier, Guillaume Lambert, et al.
Blood
|
October 22, 2010
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Hervé Avet-Loiseau, Florent Malard, Loic Campion, et al.
Nature
|
September 24, 2004
A high-intensity highly coherent soft X-ray femtosecond laser seeded by a high harmonic beam
Ph Zeitoun, G Faivre, S Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study
Emanuele Zucca, Annarita Conconi, Daniele Laszlo, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Cancer
|
March 23, 2019
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study
Nicolas Mounier, Sabine Anthony, Raphaël Busson, et al.
Optics Letters
|
May 4, 2010
Fourier-limited seeded soft x-ray laser pulse
O Guilbaud, F Tissandier, J-P Goddet, et al.
Bulletin Du Cancer
|
February 19, 2017
[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment]
Sabine Anthony, Pierre Hebel, André Garrel, et al.
Leukemia
|
April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
F Lefrère, A Delmer, F Suzan, et al.
Blood
|
January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
P Colombat, G Salles, N Brousse, et al.
Page
of 46
Search research articles
Search
Showing results (421-430 of 459) with videos related to
Sort By:
Page
of 46
Nature Communications
|
August 16, 2012
Laser-induced ultrafast demagnetization in the presence of a nanoscale magnetic domain network
Boris Vodungbo, Julien Gautier, Guillaume Lambert, et al.
Blood
|
October 22, 2010
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Hervé Avet-Loiseau, Florent Malard, Loic Campion, et al.
Nature
|
September 24, 2004
A high-intensity highly coherent soft X-ray femtosecond laser seeded by a high harmonic beam
Ph Zeitoun, G Faivre, S Sebban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study
Emanuele Zucca, Annarita Conconi, Daniele Laszlo, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Cancer
|
March 23, 2019
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study
Nicolas Mounier, Sabine Anthony, Raphaël Busson, et al.
Optics Letters
|
May 4, 2010
Fourier-limited seeded soft x-ray laser pulse
O Guilbaud, F Tissandier, J-P Goddet, et al.
Bulletin Du Cancer
|
February 19, 2017
[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment]
Sabine Anthony, Pierre Hebel, André Garrel, et al.
Leukemia
|
April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
F Lefrère, A Delmer, F Suzan, et al.
Blood
|
January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
P Colombat, G Salles, N Brousse, et al.
Page
of 46